Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for BARHL2
Z-value: 1.63
Motif logo
Transcription factors associated with BARHL2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BARHL2
|
ENSG00000143032.8 | BARHL2 |
Activity profile of BARHL2 motif
Sorted Z-values of BARHL2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of BARHL2
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_207167220 | 11.12 |
ENST00000421199.5
ENST00000457962.5 |
KLF7
|
Kruppel like factor 7 |
| chr12_-_119803383 | 8.97 |
ENST00000392520.2
ENST00000678677.1 ENST00000679249.1 ENST00000676849.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
| chr12_-_119804298 | 8.38 |
ENST00000678652.1
ENST00000678494.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
| chr19_-_50953063 | 8.19 |
ENST00000391809.6
|
KLK5
|
kallikrein related peptidase 5 |
| chr19_-_50953093 | 8.15 |
ENST00000593428.5
|
KLK5
|
kallikrein related peptidase 5 |
| chr18_+_31447732 | 7.68 |
ENST00000257189.5
|
DSG3
|
desmoglein 3 |
| chr9_+_72577939 | 6.43 |
ENST00000645773.1
|
TMC1
|
transmembrane channel like 1 |
| chr1_-_16978276 | 6.42 |
ENST00000375534.7
|
MFAP2
|
microfibril associated protein 2 |
| chr12_+_107318395 | 6.30 |
ENST00000420571.6
ENST00000280758.10 |
BTBD11
|
BTB domain containing 11 |
| chr6_+_151325665 | 6.16 |
ENST00000354675.10
|
AKAP12
|
A-kinase anchoring protein 12 |
| chr18_+_23949847 | 6.04 |
ENST00000588004.1
|
LAMA3
|
laminin subunit alpha 3 |
| chr12_-_89352395 | 5.57 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
| chr1_+_151060357 | 5.27 |
ENST00000368921.5
|
MLLT11
|
MLLT11 transcription factor 7 cofactor |
| chr17_-_40703744 | 5.16 |
ENST00000264651.3
|
KRT24
|
keratin 24 |
| chr12_-_89352487 | 5.07 |
ENST00000548755.1
ENST00000279488.8 |
DUSP6
|
dual specificity phosphatase 6 |
| chr12_-_91111460 | 5.06 |
ENST00000266718.5
|
LUM
|
lumican |
| chr4_+_168092530 | 5.04 |
ENST00000359299.8
|
ANXA10
|
annexin A10 |
| chr2_+_157257687 | 5.03 |
ENST00000259056.5
|
GALNT5
|
polypeptide N-acetylgalactosaminyltransferase 5 |
| chr2_-_207166818 | 4.91 |
ENST00000423015.5
|
KLF7
|
Kruppel like factor 7 |
| chrX_+_136169833 | 4.73 |
ENST00000628032.2
|
FHL1
|
four and a half LIM domains 1 |
| chr8_-_27838034 | 4.72 |
ENST00000522944.5
|
PBK
|
PDZ binding kinase |
| chr19_-_42877988 | 4.59 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
| chr5_+_31193678 | 4.54 |
ENST00000265071.3
|
CDH6
|
cadherin 6 |
| chr17_+_72121012 | 4.51 |
ENST00000245479.3
|
SOX9
|
SRY-box transcription factor 9 |
| chr12_-_10826358 | 4.49 |
ENST00000240619.2
|
TAS2R10
|
taste 2 receptor member 10 |
| chrX_+_136169624 | 4.48 |
ENST00000394153.6
|
FHL1
|
four and a half LIM domains 1 |
| chr17_-_41118369 | 4.42 |
ENST00000391413.4
|
KRTAP4-11
|
keratin associated protein 4-11 |
| chr5_+_31193739 | 4.38 |
ENST00000514738.5
|
CDH6
|
cadherin 6 |
| chr18_+_36544544 | 4.23 |
ENST00000591635.5
|
FHOD3
|
formin homology 2 domain containing 3 |
| chr16_+_50266530 | 4.10 |
ENST00000566433.6
ENST00000394697.7 ENST00000673801.1 |
ADCY7
|
adenylate cyclase 7 |
| chrX_+_136169664 | 4.05 |
ENST00000456445.5
|
FHL1
|
four and a half LIM domains 1 |
| chr2_-_237414157 | 4.04 |
ENST00000295550.9
ENST00000353578.9 ENST00000392004.7 ENST00000433762.1 ENST00000392003.6 |
COL6A3
|
collagen type VI alpha 3 chain |
| chr1_+_84181630 | 3.98 |
ENST00000610457.1
|
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
| chr7_-_24980148 | 3.83 |
ENST00000313367.7
|
OSBPL3
|
oxysterol binding protein like 3 |
| chr16_+_8712943 | 3.80 |
ENST00000561870.5
ENST00000396600.6 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr4_-_142305935 | 3.74 |
ENST00000511838.5
|
INPP4B
|
inositol polyphosphate-4-phosphatase type II B |
| chrX_+_136169891 | 3.47 |
ENST00000449474.5
|
FHL1
|
four and a half LIM domains 1 |
| chr5_-_147401591 | 3.38 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase like 3 |
| chr2_+_209579598 | 3.25 |
ENST00000445941.5
ENST00000673860.1 |
MAP2
|
microtubule associated protein 2 |
| chr19_+_44905785 | 3.25 |
ENST00000446996.5
ENST00000252486.9 ENST00000434152.5 |
APOE
|
apolipoprotein E |
| chr2_-_187554351 | 3.21 |
ENST00000437725.5
ENST00000409676.5 ENST00000233156.9 ENST00000339091.8 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor |
| chr2_-_237414127 | 3.19 |
ENST00000472056.5
|
COL6A3
|
collagen type VI alpha 3 chain |
| chr11_+_35180279 | 3.13 |
ENST00000531873.5
|
CD44
|
CD44 molecule (Indian blood group) |
| chr8_+_11809135 | 3.10 |
ENST00000528643.5
ENST00000525777.5 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
| chr8_-_48921419 | 3.03 |
ENST00000020945.4
|
SNAI2
|
snail family transcriptional repressor 2 |
| chr18_+_23873000 | 3.03 |
ENST00000269217.11
ENST00000587184.5 |
LAMA3
|
laminin subunit alpha 3 |
| chr1_-_200620729 | 3.03 |
ENST00000367350.5
|
KIF14
|
kinesin family member 14 |
| chr11_+_111245725 | 3.02 |
ENST00000280325.7
|
C11orf53
|
chromosome 11 open reading frame 53 |
| chr9_+_72577369 | 2.98 |
ENST00000651183.1
|
TMC1
|
transmembrane channel like 1 |
| chr1_-_152414256 | 2.95 |
ENST00000271835.3
|
CRNN
|
cornulin |
| chr8_+_22567038 | 2.93 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
| chr19_-_51034727 | 2.91 |
ENST00000525263.5
|
KLK12
|
kallikrein related peptidase 12 |
| chr5_+_36166556 | 2.84 |
ENST00000677886.1
|
SKP2
|
S-phase kinase associated protein 2 |
| chr9_+_128411715 | 2.81 |
ENST00000420034.5
ENST00000372842.5 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr11_+_33039996 | 2.72 |
ENST00000432887.5
ENST00000528898.1 ENST00000531632.6 |
TCP11L1
|
t-complex 11 like 1 |
| chr3_+_155083523 | 2.71 |
ENST00000680057.1
|
MME
|
membrane metalloendopeptidase |
| chr19_-_51034993 | 2.69 |
ENST00000684732.1
|
KLK12
|
kallikrein related peptidase 12 |
| chr2_-_70553440 | 2.66 |
ENST00000450929.5
|
TGFA
|
transforming growth factor alpha |
| chr13_+_108629605 | 2.63 |
ENST00000457511.7
|
MYO16
|
myosin XVI |
| chr5_+_151259793 | 2.60 |
ENST00000523004.1
|
GM2A
|
GM2 ganglioside activator |
| chr5_+_163460650 | 2.55 |
ENST00000358715.3
|
HMMR
|
hyaluronan mediated motility receptor |
| chr12_-_95116967 | 2.55 |
ENST00000551521.5
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
| chr18_+_58862904 | 2.52 |
ENST00000591083.5
|
ZNF532
|
zinc finger protein 532 |
| chr10_+_11823348 | 2.51 |
ENST00000277570.10
ENST00000622831.4 |
PROSER2
|
proline and serine rich 2 |
| chr6_+_26199509 | 2.51 |
ENST00000356530.5
|
H2BC7
|
H2B clustered histone 7 |
| chr7_+_107583919 | 2.50 |
ENST00000491150.5
|
BCAP29
|
B cell receptor associated protein 29 |
| chr11_+_35180342 | 2.47 |
ENST00000639002.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr4_-_159035226 | 2.44 |
ENST00000434826.3
|
C4orf45
|
chromosome 4 open reading frame 45 |
| chr22_-_32159301 | 2.43 |
ENST00000382097.4
|
C22orf42
|
chromosome 22 open reading frame 42 |
| chr6_+_29170907 | 2.41 |
ENST00000641417.1
|
OR2J2
|
olfactory receptor family 2 subfamily J member 2 |
| chr19_-_43204223 | 2.40 |
ENST00000599746.5
|
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr1_-_6261053 | 2.39 |
ENST00000377893.3
|
GPR153
|
G protein-coupled receptor 153 |
| chr1_+_84164370 | 2.37 |
ENST00000446538.5
ENST00000610703.4 ENST00000370682.7 ENST00000394838.6 ENST00000432111.5 |
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
| chr5_+_163460623 | 2.36 |
ENST00000393915.9
ENST00000432118.6 |
HMMR
|
hyaluronan mediated motility receptor |
| chr2_+_101839815 | 2.35 |
ENST00000421882.5
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr17_-_59151794 | 2.33 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
| chr19_-_51034840 | 2.33 |
ENST00000529888.5
|
KLK12
|
kallikrein related peptidase 12 |
| chr3_+_130850585 | 2.32 |
ENST00000505330.5
ENST00000504381.5 ENST00000507488.6 |
ATP2C1
|
ATPase secretory pathway Ca2+ transporting 1 |
| chr3_-_172711005 | 2.32 |
ENST00000424772.2
ENST00000475381.7 |
NCEH1
|
neutral cholesterol ester hydrolase 1 |
| chr7_-_107803215 | 2.30 |
ENST00000340010.10
ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 member 3 |
| chr10_-_88851809 | 2.29 |
ENST00000371930.5
|
ANKRD22
|
ankyrin repeat domain 22 |
| chr2_-_70553638 | 2.29 |
ENST00000444975.5
ENST00000445399.5 ENST00000295400.11 ENST00000418333.6 |
TGFA
|
transforming growth factor alpha |
| chr15_-_41972504 | 2.26 |
ENST00000220325.9
|
EHD4
|
EH domain containing 4 |
| chr5_+_151253171 | 2.26 |
ENST00000357164.4
|
GM2A
|
GM2 ganglioside activator |
| chr14_-_91253925 | 2.23 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
| chr19_+_40751179 | 2.20 |
ENST00000243563.8
ENST00000601393.1 |
SNRPA
|
small nuclear ribonucleoprotein polypeptide A |
| chr3_+_190615308 | 2.17 |
ENST00000412080.1
|
IL1RAP
|
interleukin 1 receptor accessory protein |
| chr18_+_24155938 | 2.16 |
ENST00000582229.1
|
CABYR
|
calcium binding tyrosine phosphorylation regulated |
| chr19_-_51034892 | 2.16 |
ENST00000319590.8
ENST00000250351.4 |
KLK12
|
kallikrein related peptidase 12 |
| chr20_+_43667105 | 2.12 |
ENST00000217026.5
|
MYBL2
|
MYB proto-oncogene like 2 |
| chr6_+_130018565 | 2.10 |
ENST00000361794.7
ENST00000526087.5 ENST00000533560.5 |
L3MBTL3
|
L3MBTL histone methyl-lysine binding protein 3 |
| chr18_+_63587336 | 2.09 |
ENST00000344731.10
|
SERPINB13
|
serpin family B member 13 |
| chr1_+_209704836 | 2.09 |
ENST00000367027.5
|
HSD11B1
|
hydroxysteroid 11-beta dehydrogenase 1 |
| chr12_+_15546344 | 2.08 |
ENST00000674388.1
ENST00000542557.5 ENST00000445537.6 ENST00000544244.5 ENST00000442921.7 |
PTPRO
|
protein tyrosine phosphatase receptor type O |
| chr6_+_106098933 | 2.05 |
ENST00000369089.3
|
PRDM1
|
PR/SET domain 1 |
| chr8_-_61646807 | 2.01 |
ENST00000522919.5
|
ASPH
|
aspartate beta-hydroxylase |
| chr17_-_7404039 | 2.01 |
ENST00000576017.1
ENST00000302422.4 |
TMEM256
|
transmembrane protein 256 |
| chr1_-_231421146 | 2.01 |
ENST00000667629.1
ENST00000670301.1 ENST00000658954.1 |
EGLN1
|
egl-9 family hypoxia inducible factor 1 |
| chr11_-_118264445 | 1.98 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero like 2 |
| chr1_-_110391041 | 1.98 |
ENST00000369781.8
ENST00000437429.6 ENST00000541986.5 |
SLC16A4
|
solute carrier family 16 member 4 |
| chr3_+_111911604 | 1.96 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology like domain family B member 2 |
| chr10_-_29634964 | 1.96 |
ENST00000375398.6
ENST00000355867.8 |
SVIL
|
supervillin |
| chr3_+_155083889 | 1.93 |
ENST00000680282.1
|
MME
|
membrane metalloendopeptidase |
| chr18_-_12656716 | 1.91 |
ENST00000462226.1
ENST00000497844.6 ENST00000309836.9 ENST00000453447.6 |
SPIRE1
|
spire type actin nucleation factor 1 |
| chr7_+_142750657 | 1.88 |
ENST00000492062.1
|
PRSS1
|
serine protease 1 |
| chrX_-_41665766 | 1.87 |
ENST00000643043.2
ENST00000486402.1 ENST00000646087.2 |
CASK
|
calcium/calmodulin dependent serine protein kinase |
| chr14_+_32329341 | 1.86 |
ENST00000557354.5
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A-kinase anchoring protein 6 |
| chr11_-_107719657 | 1.83 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
| chr11_+_64251483 | 1.82 |
ENST00000279230.12
ENST00000540288.5 ENST00000325234.5 |
PLCB3
|
phospholipase C beta 3 |
| chr6_+_106086316 | 1.77 |
ENST00000369091.6
ENST00000369096.9 |
PRDM1
|
PR/SET domain 1 |
| chr18_-_31760864 | 1.76 |
ENST00000269205.7
ENST00000672005.1 |
SLC25A52
|
solute carrier family 25 member 52 |
| chr14_+_73239599 | 1.74 |
ENST00000554301.5
ENST00000555445.5 |
PAPLN
|
papilin, proteoglycan like sulfated glycoprotein |
| chr2_+_33134579 | 1.74 |
ENST00000418533.6
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr3_+_183253795 | 1.71 |
ENST00000460419.1
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr5_+_136058849 | 1.71 |
ENST00000508076.5
|
TGFBI
|
transforming growth factor beta induced |
| chr15_+_40382715 | 1.70 |
ENST00000416151.6
ENST00000249776.12 |
KNSTRN
|
kinetochore localized astrin (SPAG5) binding protein |
| chr20_+_61599755 | 1.70 |
ENST00000543233.2
|
CDH4
|
cadherin 4 |
| chr6_-_110179995 | 1.69 |
ENST00000392586.5
ENST00000419252.1 ENST00000359451.6 ENST00000392588.5 |
WASF1
|
WASP family member 1 |
| chr10_-_93482326 | 1.68 |
ENST00000359263.9
|
MYOF
|
myoferlin |
| chr11_+_55811367 | 1.68 |
ENST00000625203.2
|
OR5L1
|
olfactory receptor family 5 subfamily L member 1 |
| chr21_-_30497160 | 1.67 |
ENST00000334058.3
|
KRTAP19-4
|
keratin associated protein 19-4 |
| chr4_-_73988179 | 1.66 |
ENST00000296028.4
|
PPBP
|
pro-platelet basic protein |
| chr1_-_89175997 | 1.65 |
ENST00000294671.3
ENST00000650452.1 |
GBP7
|
guanylate binding protein 7 |
| chr7_+_144000320 | 1.65 |
ENST00000641698.1
|
OR6B1
|
olfactory receptor family 6 subfamily B member 1 |
| chr5_-_126595237 | 1.64 |
ENST00000637206.1
ENST00000553117.5 |
ALDH7A1
|
aldehyde dehydrogenase 7 family member A1 |
| chr1_-_74733253 | 1.64 |
ENST00000417775.5
|
CRYZ
|
crystallin zeta |
| chr1_+_115029823 | 1.63 |
ENST00000256592.3
|
TSHB
|
thyroid stimulating hormone subunit beta |
| chr1_+_62597510 | 1.62 |
ENST00000371129.4
|
ANGPTL3
|
angiopoietin like 3 |
| chr17_-_17281232 | 1.61 |
ENST00000417352.5
ENST00000268717.10 |
COPS3
|
COP9 signalosome subunit 3 |
| chr13_+_108596152 | 1.61 |
ENST00000356711.7
ENST00000251041.10 |
MYO16
|
myosin XVI |
| chr3_+_155080307 | 1.60 |
ENST00000360490.7
|
MME
|
membrane metalloendopeptidase |
| chr10_-_14330879 | 1.59 |
ENST00000357447.7
|
FRMD4A
|
FERM domain containing 4A |
| chr17_+_58692563 | 1.59 |
ENST00000461271.5
ENST00000583539.5 ENST00000337432.9 ENST00000421782.3 |
RAD51C
|
RAD51 paralog C |
| chr9_+_34329545 | 1.58 |
ENST00000379158.7
|
NUDT2
|
nudix hydrolase 2 |
| chr16_+_8713614 | 1.58 |
ENST00000567812.5
|
ABAT
|
4-aminobutyrate aminotransferase |
| chr7_+_77840122 | 1.57 |
ENST00000450574.5
ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
| chr3_+_183253230 | 1.57 |
ENST00000326505.4
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr15_+_40382764 | 1.57 |
ENST00000448395.6
|
KNSTRN
|
kinetochore localized astrin (SPAG5) binding protein |
| chr4_+_105710809 | 1.55 |
ENST00000360505.9
ENST00000510865.5 ENST00000509336.5 |
GSTCD
|
glutathione S-transferase C-terminal domain containing |
| chr17_-_41055211 | 1.54 |
ENST00000542910.1
ENST00000398477.1 |
KRTAP2-2
|
keratin associated protein 2-2 |
| chr3_+_150408314 | 1.54 |
ENST00000361875.7
|
TSC22D2
|
TSC22 domain family member 2 |
| chr4_-_142305826 | 1.53 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase type II B |
| chr12_+_93572664 | 1.53 |
ENST00000551556.2
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr1_-_156705742 | 1.52 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr7_-_13986439 | 1.51 |
ENST00000443608.5
ENST00000438956.5 |
ETV1
|
ETS variant transcription factor 1 |
| chr1_+_43935807 | 1.51 |
ENST00000438616.3
|
ARTN
|
artemin |
| chr11_+_73272201 | 1.51 |
ENST00000393590.3
|
P2RY6
|
pyrimidinergic receptor P2Y6 |
| chr12_-_56934403 | 1.49 |
ENST00000293502.2
|
SDR9C7
|
short chain dehydrogenase/reductase family 9C member 7 |
| chr4_+_37826660 | 1.48 |
ENST00000625312.2
ENST00000381967.9 |
PGM2
|
phosphoglucomutase 2 |
| chr6_-_111606260 | 1.48 |
ENST00000340026.10
|
TRAF3IP2
|
TRAF3 interacting protein 2 |
| chr6_+_121435595 | 1.48 |
ENST00000649003.1
ENST00000282561.4 |
GJA1
|
gap junction protein alpha 1 |
| chr18_+_58221535 | 1.48 |
ENST00000431212.6
ENST00000586268.5 ENST00000587190.5 |
NEDD4L
|
NEDD4 like E3 ubiquitin protein ligase |
| chrX_+_50067576 | 1.47 |
ENST00000376108.7
|
CLCN5
|
chloride voltage-gated channel 5 |
| chr1_-_155255441 | 1.47 |
ENST00000361361.7
ENST00000621094.4 |
FAM189B
|
family with sequence similarity 189 member B |
| chr6_-_45377860 | 1.47 |
ENST00000371460.5
ENST00000371459.6 |
SUPT3H
|
SPT3 homolog, SAGA and STAGA complex component |
| chr4_-_52020332 | 1.46 |
ENST00000682860.1
|
LRRC66
|
leucine rich repeat containing 66 |
| chr22_-_35961623 | 1.45 |
ENST00000408983.2
|
RBFOX2
|
RNA binding fox-1 homolog 2 |
| chr22_-_50085331 | 1.44 |
ENST00000395876.6
|
MLC1
|
modulator of VRAC current 1 |
| chr17_-_66229380 | 1.44 |
ENST00000205948.11
|
APOH
|
apolipoprotein H |
| chr4_+_143381939 | 1.43 |
ENST00000505913.5
|
GAB1
|
GRB2 associated binding protein 1 |
| chr19_+_15728024 | 1.40 |
ENST00000305899.5
|
OR10H2
|
olfactory receptor family 10 subfamily H member 2 |
| chr1_-_156705764 | 1.40 |
ENST00000621784.4
ENST00000368220.1 |
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr15_+_40382926 | 1.40 |
ENST00000608100.5
ENST00000557920.1 |
KNSTRN
|
kinetochore localized astrin (SPAG5) binding protein |
| chr14_-_67412112 | 1.39 |
ENST00000216446.9
|
PLEK2
|
pleckstrin 2 |
| chr19_+_7030578 | 1.38 |
ENST00000329753.5
|
MBD3L5
|
methyl-CpG binding domain protein 3 like 5 |
| chr2_-_89143133 | 1.38 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr18_-_36122110 | 1.38 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 member 6 |
| chr18_+_58149314 | 1.37 |
ENST00000435432.6
ENST00000357895.9 ENST00000586263.5 |
NEDD4L
|
NEDD4 like E3 ubiquitin protein ligase |
| chr3_+_159069252 | 1.37 |
ENST00000640015.1
ENST00000476809.7 ENST00000485419.7 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr9_+_131289685 | 1.35 |
ENST00000372264.4
|
PLPP7
|
phospholipid phosphatase 7 (inactive) |
| chr1_+_43979179 | 1.32 |
ENST00000434555.7
ENST00000372324.6 ENST00000481924.2 |
B4GALT2
|
beta-1,4-galactosyltransferase 2 |
| chr5_+_55024250 | 1.32 |
ENST00000231009.3
|
GZMK
|
granzyme K |
| chr11_+_70398404 | 1.32 |
ENST00000346329.7
ENST00000301843.13 ENST00000376561.7 |
CTTN
|
cortactin |
| chr9_-_92482499 | 1.32 |
ENST00000375544.7
|
ASPN
|
asporin |
| chr16_-_58546702 | 1.31 |
ENST00000567133.1
|
CNOT1
|
CCR4-NOT transcription complex subunit 1 |
| chr12_+_54280842 | 1.31 |
ENST00000678077.1
ENST00000548688.5 |
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1 |
| chr11_-_18236795 | 1.31 |
ENST00000278222.7
|
SAA4
|
serum amyloid A4, constitutive |
| chr14_-_24141570 | 1.30 |
ENST00000560403.5
ENST00000419198.6 ENST00000216799.9 |
EMC9
|
ER membrane protein complex subunit 9 |
| chr1_-_205680486 | 1.29 |
ENST00000367145.4
|
SLC45A3
|
solute carrier family 45 member 3 |
| chr12_-_52777343 | 1.29 |
ENST00000332411.2
|
KRT76
|
keratin 76 |
| chr1_-_243163310 | 1.28 |
ENST00000492145.1
ENST00000490813.5 ENST00000464936.5 |
CEP170
|
centrosomal protein 170 |
| chr13_+_31739520 | 1.28 |
ENST00000298386.7
|
RXFP2
|
relaxin family peptide receptor 2 |
| chr1_-_197067234 | 1.28 |
ENST00000367412.2
|
F13B
|
coagulation factor XIII B chain |
| chr4_-_39977836 | 1.28 |
ENST00000303538.13
ENST00000503396.5 |
PDS5A
|
PDS5 cohesin associated factor A |
| chr11_+_73272332 | 1.28 |
ENST00000540124.6
ENST00000536225.2 |
P2RY6
|
pyrimidinergic receptor P2Y6 |
| chr4_+_70721953 | 1.27 |
ENST00000381006.8
ENST00000226328.8 |
RUFY3
|
RUN and FYVE domain containing 3 |
| chr2_-_171433950 | 1.27 |
ENST00000375258.9
ENST00000442541.1 ENST00000392599.6 |
METTL8
|
methyltransferase like 8 |
| chr9_+_107306459 | 1.26 |
ENST00000457811.1
|
RAD23B
|
RAD23 homolog B, nucleotide excision repair protein |
| chr3_-_47892743 | 1.26 |
ENST00000420772.6
|
MAP4
|
microtubule associated protein 4 |
| chr3_-_132684685 | 1.25 |
ENST00000512094.5
ENST00000632629.1 |
NPHP3
NPHP3-ACAD11
|
nephrocystin 3 NPHP3-ACAD11 readthrough (NMD candidate) |
| chr4_-_20984011 | 1.24 |
ENST00000382149.9
|
KCNIP4
|
potassium voltage-gated channel interacting protein 4 |
| chr6_+_29100609 | 1.23 |
ENST00000377171.3
|
OR2J1
|
olfactory receptor family 2 subfamily J member 1 |
| chr17_+_68525795 | 1.22 |
ENST00000592800.5
|
PRKAR1A
|
protein kinase cAMP-dependent type I regulatory subunit alpha |
| chr12_-_91153149 | 1.22 |
ENST00000550758.1
|
DCN
|
decorin |
| chr1_+_50103903 | 1.22 |
ENST00000371827.5
|
ELAVL4
|
ELAV like RNA binding protein 4 |
| chr12_+_21527017 | 1.21 |
ENST00000535033.5
|
SPX
|
spexin hormone |
| chr11_+_121102666 | 1.21 |
ENST00000264037.2
|
TECTA
|
tectorin alpha |
| chr10_+_5196831 | 1.21 |
ENST00000263126.3
|
AKR1C4
|
aldo-keto reductase family 1 member C4 |
| chr12_+_26195313 | 1.21 |
ENST00000422622.3
|
SSPN
|
sarcospan |
| chr12_+_71664352 | 1.21 |
ENST00000547843.1
|
THAP2
|
THAP domain containing 2 |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 16.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.1 | 10.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 1.5 | 4.5 | GO:0072034 | primary prostatic bud elongation(GO:0060516) renal vesicle induction(GO:0072034) |
| 1.3 | 5.4 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.3 | 3.8 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 1.1 | 3.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 1.0 | 3.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.0 | 6.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.9 | 6.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 | 7.7 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.7 | 2.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.6 | 6.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.5 | 4.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.5 | 2.1 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.5 | 3.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.5 | 6.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 | 5.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.5 | 3.0 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.5 | 2.0 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) |
| 0.5 | 2.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.5 | 5.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.4 | 2.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.4 | 2.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 | 2.5 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.4 | 1.6 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 2.0 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 2.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.4 | 2.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.4 | 1.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.4 | 1.5 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.4 | 3.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 | 2.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 1.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.3 | 4.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.3 | 1.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 | 20.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.3 | 9.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 1.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 | 1.0 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 2.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.3 | 1.5 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 | 1.8 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 2.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 1.2 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.3 | 2.3 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 0.3 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.3 | 4.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 | 0.8 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.3 | 1.0 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.3 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.3 | 1.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 | 2.5 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.2 | 1.0 | GO:0032903 | viral protein processing(GO:0019082) negative regulation of neurotrophin production(GO:0032900) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.2 | 2.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 3.3 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.2 | 1.2 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.2 | 2.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.2 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 0.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.2 | 0.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 | 2.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.2 | 0.7 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.2 | 4.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.2 | 18.9 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.2 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 5.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.2 | 1.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 0.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 | 0.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 | 1.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 | 25.6 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 0.8 | GO:0015855 | canalicular bile acid transport(GO:0015722) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.2 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 2.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 0.8 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
| 0.2 | 4.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 1.9 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 1.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 0.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 | 2.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 1.6 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.2 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 0.9 | GO:0061518 | microglial cell activation involved in immune response(GO:0002282) macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 0.2 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.2 | 0.8 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.7 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 2.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 | 0.8 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 | 0.4 | GO:1900390 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.1 | 0.4 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.1 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 1.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.1 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 2.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 4.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.9 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 1.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 1.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 1.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 1.7 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 1.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 | 0.4 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.1 | 0.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 1.1 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.1 | 2.5 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 2.2 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.3 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 1.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 1.2 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 0.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 2.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 5.3 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.3 | GO:1990086 | proximal/distal axis specification(GO:0009946) lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 1.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 | 0.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 2.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.7 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 | 0.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.1 | GO:0090134 | mesendoderm development(GO:0048382) mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 1.8 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 1.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.1 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.1 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
| 0.1 | 2.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.9 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 0.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.1 | 1.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 3.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.3 | GO:1903611 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 0.1 | 1.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
| 0.1 | 1.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.8 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 1.4 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.3 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 0.2 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.1 | 5.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.9 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.6 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 | 2.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 5.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 1.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 14.9 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.1 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.1 | 0.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 3.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 1.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 4.8 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 1.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 1.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 0.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.4 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 1.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.8 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.2 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.1 | 1.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 1.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.1 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 2.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 8.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 | 0.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 1.4 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.0 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 1.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 1.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 1.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 | 0.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.0 | 2.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.1 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.4 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
| 0.0 | 2.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 7.2 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 | 2.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.8 | GO:0090128 | regulation of synapse maturation(GO:0090128) positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 0.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 2.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 2.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.5 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 1.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 2.5 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.8 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.0 | 7.0 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.0 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 2.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
| 0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 | 1.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.3 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.3 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 2.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.2 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 | 0.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 1.5 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.9 | GO:0034080 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 4.8 | GO:0009408 | response to heat(GO:0009408) |
| 0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 | 0.4 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
| 0.0 | 2.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 | 0.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.0 | 1.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.0 | 2.0 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 1.2 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
| 0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.6 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.5 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.0 | 0.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 1.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.0 | GO:1903823 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.0 | 0.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.0 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
| 0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 2.6 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 | 0.6 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 16.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.3 | 5.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.3 | 9.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.2 | 4.9 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.8 | 3.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.5 | 3.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.5 | 2.2 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.5 | 9.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 5.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.5 | 6.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.5 | 1.4 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.4 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.4 | 8.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 5.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.4 | 7.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 4.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.3 | 1.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.3 | 1.3 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 2.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 0.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 7.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 2.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.2 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) periciliary membrane compartment(GO:1990075) |
| 0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 2.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 0.8 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.1 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 0.9 | GO:0097169 | IPAF inflammasome complex(GO:0072557) AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 5.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 2.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 17.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 4.3 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 2.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 1.2 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 1.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 1.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 7.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 1.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 1.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 4.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 2.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 2.4 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.9 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 3.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 11.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.4 | GO:0044218 | extrinsic component of external side of plasma membrane(GO:0031232) other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 1.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 2.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 4.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 1.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 37.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.3 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.1 | 1.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 3.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 2.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 2.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.0 | 1.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.0 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 3.1 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 5.7 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.0 | 2.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 2.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 2.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 2.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 4.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 5.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.3 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 2.3 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 2.3 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.0 | 2.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 4.9 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 1.3 | 5.4 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.1 | 3.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.9 | 5.3 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.7 | 2.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.7 | 9.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.7 | 3.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.6 | 10.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.5 | 3.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.5 | 2.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.5 | 9.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 2.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.5 | 2.8 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.5 | 1.8 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.4 | 2.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.4 | 1.6 | GO:0070404 | NADH binding(GO:0070404) |
| 0.4 | 6.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 2.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.3 | 1.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 4.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 1.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.3 | 1.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.3 | 4.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 2.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 1.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.3 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 11.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.3 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 5.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 1.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 0.7 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.2 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 1.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.2 | 0.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 4.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.2 | 1.5 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.2 | 2.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 1.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 16.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 4.3 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 1.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 0.4 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.1 | 2.9 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.1 | 2.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 2.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 1.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.1 | 3.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 14.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 2.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 1.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 2.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 5.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 2.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 5.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 8.9 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 3.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 1.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 3.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 1.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 22.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.2 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.1 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 2.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 0.3 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.1 | 1.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 2.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 1.1 | GO:0030297 | ErbB-2 class receptor binding(GO:0005176) transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 2.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.2 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.1 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 6.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 10.5 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 1.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 1.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.0 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 4.9 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 5.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 4.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 0.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.0 | 1.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 1.5 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 15.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 1.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 1.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 5.5 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 18.6 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.0 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 8.1 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 5.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 1.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 6.3 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 1.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 9.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 17.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 10.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 4.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 10.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 5.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 7.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 7.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 3.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 6.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 3.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 4.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 7.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 3.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 3.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 2.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 2.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 3.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 1.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 2.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 3.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 4.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 3.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 1.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 6.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 1.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 2.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.0 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 10.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 10.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 12.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.3 | 7.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 9.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 3.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 11.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 2.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 5.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 2.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 3.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 3.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 4.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 3.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 8.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 2.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 1.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 4.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 3.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 3.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 1.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 2.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 2.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 1.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 1.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 1.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 5.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 1.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 1.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.0 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 1.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 3.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.0 | 1.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.0 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 4.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 3.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 1.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 1.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.8 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.0 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 0.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 1.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |